Nurix Pretax Profit Margin vs Gross Profit Margin Analysis

NRIX Stock

USD 20.02 0.37 1.88%

Nurix Therapeutics financial indicator trend analysis is infinitely more than just investigating Nurix Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nurix Therapeutics is a good investment. Please check the relationship between Nurix Therapeutics Pretax Profit Margin and its Gross Profit Margin accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Nurix Stock please use our How to Invest in Nurix Therapeutics guide.

Pretax Profit Margin vs Gross Profit Margin

Pretax Profit Margin vs Gross Profit Margin Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nurix Therapeutics Pretax Profit Margin account and Gross Profit Margin. At this time, the significance of the direction appears to have weak relationship.

The correlation between Nurix Therapeutics' Pretax Profit Margin and Gross Profit Margin is 0.33. Overlapping area represents the amount of variation of Pretax Profit Margin that can explain the historical movement of Gross Profit Margin in the same time period over historical financial statements of Nurix Therapeutics, assuming nothing else is changed. The correlation between historical values of Nurix Therapeutics' Pretax Profit Margin and Gross Profit Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pretax Profit Margin of Nurix Therapeutics are associated (or correlated) with its Gross Profit Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Gross Profit Margin has no effect on the direction of Pretax Profit Margin i.e., Nurix Therapeutics' Pretax Profit Margin and Gross Profit Margin go up and down completely randomly.

Correlation Coefficient

0.33

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Pretax Profit Margin

Gross Profit Margin

Most indicators from Nurix Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nurix Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nurix Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Nurix Stock please use our How to Invest in Nurix Therapeutics guide.At this time, Nurix Therapeutics' Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 577.8 M in 2025, whereas Selling General Administrative is likely to drop slightly above 29.8 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Income	11.1M	19.7M	22.7M	23.8M
Net Interest Income	11.1M	19.7M	22.7M	23.8M

Interest Income Net Interest Income

Nurix Therapeutics fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.95	0.87	1.0	0.76	0.86	0.91	0.7	-0.77	-0.91	0.97	0.88	0.7	0.8	0.21	0.99	0.87	0.82	0.98	-0.15	0.95	0.92	0.98	0.88	1.0	0.9
Other Current Liab	0.95		0.88	0.94	0.6	0.75	0.97	0.68	-0.59	-0.97	0.98	0.76	0.48	0.81	0.04	0.98	0.79	0.86	0.99	-0.22	0.92	0.83	0.99	0.87	0.94	0.98
Total Current Liabilities	0.87	0.88		0.86	0.59	0.88	0.92	0.86	-0.51	-0.93	0.87	0.78	0.58	0.93	0.03	0.86	0.91	0.9	0.87	-0.23	0.91	0.93	0.9	0.92	0.86	0.88
Total Stockholder Equity	1.0	0.94	0.86		0.76	0.86	0.9	0.7	-0.78	-0.9	0.97	0.89	0.7	0.79	0.23	0.99	0.87	0.81	0.98	-0.18	0.94	0.91	0.98	0.86	1.0	0.88
Other Liab	0.76	0.6	0.59	0.76		0.85	0.6	0.44	-0.83	-0.59	0.64	0.84	0.86	0.61	0.52	0.68	0.84	0.64	0.65	0.41	0.78	0.8	0.66	0.77	0.76	0.54
Net Tangible Assets	0.86	0.75	0.88	0.86	0.85		0.79	0.81	-0.74	-0.79	0.76	0.88	0.86	0.86	0.37	0.8	0.99	0.78	0.78	0.01	0.93	0.97	0.81	0.89	0.86	0.71
Property Plant And Equipment Net	0.91	0.97	0.92	0.9	0.6	0.79		0.77	-0.47	-0.98	0.95	0.69	0.54	0.9	-0.06	0.93	0.83	0.89	0.94	-0.14	0.95	0.86	0.96	0.92	0.9	0.98
Current Deferred Revenue	0.7	0.68	0.86	0.7	0.44	0.81	0.77		-0.38	-0.72	0.67	0.59	0.63	0.8	0.1	0.66	0.8	0.59	0.67	-0.32	0.79	0.79	0.71	0.74	0.7	0.71
Net Debt	-0.77	-0.59	-0.51	-0.78	-0.83	-0.74	-0.47	-0.38		0.52	-0.63	-0.92	-0.7	-0.38	-0.73	-0.72	-0.71	-0.44	-0.67	-0.02	-0.66	-0.68	-0.65	-0.55	-0.78	-0.46
Retained Earnings	-0.91	-0.97	-0.93	-0.9	-0.59	-0.79	-0.98	-0.72	0.52		-0.94	-0.73	-0.48	-0.89	0.03	-0.93	-0.83	-0.92	-0.95	0.18	-0.93	-0.87	-0.96	-0.9	-0.9	-0.97
Accounts Payable	0.97	0.98	0.87	0.97	0.64	0.76	0.95	0.67	-0.63	-0.94		0.79	0.55	0.79	0.03	0.99	0.79	0.86	0.99	-0.18	0.91	0.85	0.99	0.88	0.97	0.96
Cash	0.88	0.76	0.78	0.89	0.84	0.88	0.69	0.59	-0.92	-0.73	0.79		0.7	0.65	0.54	0.85	0.88	0.71	0.81	-0.04	0.81	0.87	0.81	0.8	0.89	0.68
Non Current Assets Total	0.7	0.48	0.58	0.7	0.86	0.86	0.54	0.63	-0.7	-0.48	0.55	0.7		0.64	0.38	0.58	0.82	0.5	0.55	0.18	0.75	0.8	0.58	0.65	0.7	0.42
Non Currrent Assets Other	0.8	0.81	0.93	0.79	0.61	0.86	0.9	0.8	-0.38	-0.89	0.79	0.65	0.64		-0.09	0.77	0.9	0.91	0.79	-0.11	0.92	0.92	0.83	0.89	0.79	0.82
Other Assets	0.21	0.04	0.03	0.23	0.52	0.37	-0.06	0.1	-0.73	0.03	0.03	0.54	0.38	-0.09		0.15	0.31	-0.12	0.09	0.17	0.17	0.18	0.09	0.09	0.23	-0.06
Cash And Short Term Investments	0.99	0.98	0.86	0.99	0.68	0.8	0.93	0.66	-0.72	-0.93	0.99	0.85	0.58	0.77	0.15		0.82	0.83	1.0	-0.21	0.92	0.87	0.99	0.86	0.99	0.93
Common Stock Total Equity	0.87	0.79	0.91	0.87	0.84	0.99	0.83	0.8	-0.71	-0.83	0.79	0.88	0.82	0.9	0.31	0.82		0.83	0.8	0.0	0.94	0.98	0.84	0.91	0.87	0.75
Common Stock Shares Outstanding	0.82	0.86	0.9	0.81	0.64	0.78	0.89	0.59	-0.44	-0.92	0.86	0.71	0.5	0.91	-0.12	0.83	0.83		0.84	0.02	0.86	0.88	0.86	0.93	0.81	0.87
Short Term Investments	0.98	0.99	0.87	0.98	0.65	0.78	0.94	0.67	-0.67	-0.95	0.99	0.81	0.55	0.79	0.09	1.0	0.8	0.84		-0.24	0.92	0.86	1.0	0.86	0.98	0.95
Non Current Liabilities Total	-0.15	-0.22	-0.23	-0.18	0.41	0.01	-0.14	-0.32	-0.02	0.18	-0.18	-0.04	0.18	-0.11	0.17	-0.21	0.0	0.02	-0.24		-0.09	-0.08	-0.22	0.13	-0.18	-0.17
Capital Surpluse	0.95	0.92	0.91	0.94	0.78	0.93	0.95	0.79	-0.66	-0.93	0.91	0.81	0.75	0.92	0.17	0.92	0.94	0.86	0.92	-0.09		0.95	0.95	0.92	0.94	0.89
Other Current Assets	0.92	0.83	0.93	0.91	0.8	0.97	0.86	0.79	-0.68	-0.87	0.85	0.87	0.8	0.92	0.18	0.87	0.98	0.88	0.86	-0.08	0.95		0.88	0.92	0.91	0.8
Other Stockholder Equity	0.98	0.99	0.9	0.98	0.66	0.81	0.96	0.71	-0.65	-0.96	0.99	0.81	0.58	0.83	0.09	0.99	0.84	0.86	1.0	-0.22	0.95	0.88		0.88	0.98	0.96
Total Liab	0.88	0.87	0.92	0.86	0.77	0.89	0.92	0.74	-0.55	-0.9	0.88	0.8	0.65	0.89	0.09	0.86	0.91	0.93	0.86	0.13	0.92	0.92	0.88		0.86	0.89
Net Invested Capital	1.0	0.94	0.86	1.0	0.76	0.86	0.9	0.7	-0.78	-0.9	0.97	0.89	0.7	0.79	0.23	0.99	0.87	0.81	0.98	-0.18	0.94	0.91	0.98	0.86		0.88
Property Plant And Equipment Gross	0.9	0.98	0.88	0.88	0.54	0.71	0.98	0.71	-0.46	-0.97	0.96	0.68	0.42	0.82	-0.06	0.93	0.75	0.87	0.95	-0.17	0.89	0.8	0.96	0.89	0.88

Click cells to compare fundamentals

Nurix Therapeutics Account Relationship Matchups

Nurix Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	476.8M	416.8M	355.6M	669.3M	769.7M	808.2M
Other Current Liab	10.6M	16.8M	24.9M	38.0M	43.7M	45.9M
Total Current Liabilities	66.3M	70.7M	87.0M	95.9M	110.2M	64.9M
Total Stockholder Equity	342.3M	303.7M	200.5M	527.0M	606.0M	636.3M
Other Liab	37.4M	61.5M	59.0M	36.0M	41.4M	42.9M
Net Tangible Assets	(57.7M)	290.3M	342.3M	303.7M	349.3M	185.2M
Property Plant And Equipment Net	25.3M	29.5M	48.0M	45.9M	52.8M	55.4M
Current Deferred Revenue	41.2M	37.6M	48.1M	38.4M	44.1M	37.1M
Net Debt	(67.5M)	(52.5M)	(24.0M)	(81.7M)	(73.5M)	(77.2M)
Retained Earnings	(220.9M)	(401.3M)	(545.2M)	(738.8M)	(664.9M)	(631.6M)
Accounts Payable	6.7M	5.1M	6.4M	11.5M	13.2M	13.9M
Cash	80.5M	64.5M	54.6M	110.0M	126.5M	76.9M
Non Current Assets Total	165.7M	98.3M	60.1M	50.0M	57.4M	75.6M
Non Currrent Assets Other	3.1M	4.9M	4.7M	4.1M	4.7M	2.8M
Other Assets	317K	91.2M	3.1M	4.9M	5.7M	5.4M
Cash And Short Term Investments	295.7M	309.1M	287.9M	609.6M	701.0M	736.1M
Common Stock Total Equity	4K	39K	45K	47K	54.1K	30.4K
Common Stock Shares Outstanding	42.9M	48.6M	54.3M	67.1M	77.2M	44.6M
Short Term Investments	215.2M	244.7M	233.3M	499.6M	574.5M	603.3M
Liabilities And Stockholders Equity	476.8M	416.8M	355.6M	669.3M	769.7M	808.2M
Non Current Liabilities Total	68.2M	42.4M	68.1M	46.5M	41.8M	48.2M
Capital Surpluse	2.7M	393.8M	563.8M	709.2M	815.6M	856.4M
Other Current Assets	9.4M	9.3M	7.6M	9.8M	11.3M	7.1M
Other Stockholder Equity	563.8M	709.2M	746.3M	1.3B	1.5B	1.5B
Total Liab	134.5M	113.1M	155.1M	142.4M	163.7M	131.2M
Net Invested Capital	342.3M	303.7M	200.5M	527.0M	606.0M	636.3M
Property Plant And Equipment Gross	25.3M	29.5M	74.2M	80.4M	92.5M	97.1M
Total Current Assets	311.1M	318.4M	295.5M	619.4M	712.3M	747.9M
Accumulated Other Comprehensive Income	(608K)	(4.3M)	(655K)	150K	135K	141.8K
Capital Stock	45K	47K	49K	76K	87.4K	91.8K
Non Current Liabilities Other	1.7M	850K	68.2M	42.4M	48.8M	25.2M
Net Working Capital	244.9M	247.8M	208.5M	523.5M	602.1M	632.2M
Short Term Debt	7.7M	11.1M	13.9M	8.0M	9.2M	8.8M
Common Stock	45K	47K	49K	76K	87.4K	91.8K
Property Plant Equipment	3.9M	6.7M	25.3M	17.2M	19.7M	12.6M
Capital Lease Obligations	13.0M	12.0M	30.6M	28.3M	32.5M	18.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for Nurix Stock Analysis

When running Nurix Therapeutics' price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nurix Pretax Profit Margin vs Gross Profit Margin Analysis

Pretax Profit Margin vs Gross Profit Margin

Pretax Profit Margin vs Gross Profit Margin Correlation Analysis

Correlation Coefficient

Pretax Profit Margin

Gross Profit Margin

Nurix Therapeutics fundamental ratios Correlations

Nurix Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nurix Therapeutics fundamental ratios Accounts

Also Currently Popular

Additional Tools for Nurix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Short Term Investments	+ 1.0	Cash And Short Term Investments
Other Stockholder Equity	+ 1.0	Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets

Retained Earnings	- 0.98	Property Plant And Equipment Net
Property Plant And Equipment Gross	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Other Current Liab
Other Stockholder Equity	- 0.96	Retained Earnings
Short Term Investments	- 0.95	Retained Earnings
Accounts Payable	- 0.94	Retained Earnings